Skip to content

Comparing Clonidine With Dexmedetomidine As Premedicant to Spinal 5 milligrams per ml Heavy Levobupivacaine for Prolonging Postop Analgesia

Clonidine Versus Dexmedetomidine As Premedication to Intrathecal 0.5percent Levobupivacaine Heavy - nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/08/072850
Enrollment
100
Registered
2024-08-21
Start date
Unknown
Completion date
Unknown
Last updated
2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical Health Condition 2: M958- Other specified acquired deformities of musculoskeletal system

Interventions

Intervention1: 0.75 microgram per kilogram dexmedetomidine as a premedication to 0.5% intrathecal levobupivacaine: 0.75 microgram per kilogram dexmedetomidine will be administered intravenously over

Sponsors

velammal medical college and hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.All adult patients with ASA physical status I or II 2.either sex 3.18–60 years age 4.48–90 kg weight, 151–180 cm height and body mass index (BMI) between 20 and 35 kg/m2

Exclusion criteria

Exclusion criteria: We excluded the patients 1.with known hypersensitivity to LA, 2.infection at the injection site 3.history of bleeding disorders or on anticoagulants, 4.pregnancy, anatomical abnormality, and any comorbid condition such as preexisting peripheral neuropathy or neurological deficit, cerebrovascular accidents, endocrine, severe hepatic and renal dysfunction, chronic obstructive pulmonary disease, diabetes, sepsis, heart blocks, or dysrhythmias. Patients on tranquilizers, hypnotics, sedatives, and other psychotropic drugs and drug addicts to opium or alcohol.

Design outcomes

Primary

MeasureTime frame
onset of sensory block Time taken to achieve highest level onset of motor blockade Recovery of sensory block Recovery of motor block Duration of analgesia Timepoint: Results will be assessed between 4 and 8 weeks

Secondary

MeasureTime frame
Heart rate Mean arterial pressureTimepoint: secondary parameters were noted before premedication,2 mins after premedication,60 seconds after dural puncture,15mins,20 mins,25 mins,30 mins,40 mins,50 mins,60 mins,70 mins,80 mins,90 mins,120 mins, and 180 mins after dural puncture

Countries

India

Contacts

Public ContactDR.T.NIRMALA DEVI

Velammal Hospital and Medical College

radhakrishnan04562@gmail.com95000025879

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026